not a pharmacist, just the tech side, but people miss a lot about trial logistics. trial compounds are tracked way stricter than what you get from a compounding pharmacy. every vial gets a serial number, temperature logs, expiration to the hour. most require specific storage - fridge or freezer depending on the drug. i watched someone enroll, get the vial home, and realize they don’t have fridge space. had to ask the trial to store it at our location. massive hassle. compliance is the real filter.
you return unused vials. keep a log. hit appointment windows. some randomize dosing without telling you if you got active or placebo. people drop out over the logistics, not side effects. call the trial pharmacy before enrolling - not the clinic. ask what storage you actually need, whether they’ll work with you if you miss an appt, what happens if the compound gets disposed. that’s the real question. whether it works isn’t my lane, so i won’t pretend.
one thing nobody flags in these threads is excursion logging. trial vials get continuous temp monitoring (usually a stick-on logger or NIST-traceable data logger in the shipper), and any deviation outside the labeled range, even a 20 minute window above 8C, triggers a quarantine review. i’ve seen people get a vial pulled from their kit because the kitchen fridge cycled warm during a defrost, and the door sensor caught it. the trial pharmacy doesn’t always tell the participant that’s why the next dose is delayed. if you live somewhere with unreliable power or you’re traveling, that part of the protocol matters more than people realize. iirc some longevity trials (the rapamycin and metformin ones especially) are now sending dataloggers home with participants by default, which is a non-trivial compliance burden but also useful data for the sponsor. the other thing that catches people: dispensing windows. some protocols require the vial to be used within X hours of first puncture, and that clock starts at the pharmacy, not at your kitchen counter. so if FedEx holds the package an extra day, you’ve already burned half your in-use stability before you’ve drawn a dose. ask specifically about beyond-use dating vs labeled expiration. those are different numbers and the pharmacy will know which one applies. re logistics being the actual filter, agreed and i’d extend it: the participants who succeed are usually the ones who already have a habit of logging something daily. a structured check-in flow you actually do beats a spreadsheet you swear you’ll fill in on sunday. ymmv but the dropout data i’ve seen tracks with self-reported tracking habits at intake more than it does with the drug arm.
‘the trial pharmacy doesn’t always tell the participant’ - but the actual gap is the replacement timeline when a vial gets quarantined. ime some hit 24h re-ship, others take a week and your schedule just shifts around it. that’s not usually in the enrollment materials. ask the trial whether they have a backup vial protocol before you sign.
asking about replacement timeline is the right instinct, but “backup vial protocol” isn’t usually a thing trials have on paper, at least not in the materials i’ve seen. what’s actually happening when a vial gets quarantined is the IDS pharmacist calls the sponsor depot or central pharmacy, and the re-ship window is a function of where that depot sits, which courier they’re contracted with, and whether your site is a primary or a satellite. there’s no SOP titled “backup” you can ask to see. the sharper version of the question is: where does re-supply ship from, and is it domestic or international. domestic depot with a same-day courier contract is your 24h re-ship. central depot in switzerland going through customs is your week. that variable explains most of the variance you’re describing, not whether the trial bothered to formalize a protocol. other thing worth flagging: the enrollment coordinator usually doesn’t know any of this. the person who actually knows is the investigational drug services pharmacist at the site, and they’re frequently a different human than the clinical staff you meet at screening. ask to talk to them by name before you sign, not “the trial pharmacy” as a category, because half the time the coordinator will just guess and you’ll get an answer that doesn’t survive contact with reality. agree on people dropping out over logistics more than tox, that lines up with what i’ve read. the part i’d add is that even when re-supply works smoothly, the shift cascades into your followup PK draws and lab windows, and if you’re tracking anything yourself the gap is visible in the data months later. (the correlation view in careclinic pulled out a dosing-gap vs sleep pattern for me on an unrelated cycle i’d been squinting at in a spreadsheet for weeks.) ymmv on whether the site documents the excursion in your file or just quietly reships and moves on, and that distinction matters if you ever want to reconstruct what actually happened with your own dosing later.